Article
BRCA mutations and prostate cancer: should urologist improve daily clinical practice?
17 Apr 2025
Abstract excerpt
INTRODUCTION: To evaluate BRCA1-2 (breast cancer) detection in men with high risk PCa, including the oncological consequences for the patient and family members. MATERIALS AND METHODS: From January 2023 to December 2024, 52 men (median age 73 years;) with confirmed PCa diagnosis underwent somatic and germline BRCA1 and BRCA2 assessment; 11/52 (21%) patients documented a family history of cancer. Patients were at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
